Product logins

Find logins to all Clarivate products below.


Keval Vasavada

Director, Consulting

Keval Vasavada comes with a right mix of consulting as well as industry experience in pharmaceutical and life sciences.

He holds over 13 years of experience spanning corporate strategy, operations, new process set-up, new product launches, corporate finance, fund raising and commercial deals. Prior to Clarivate, Keval worked with Cipla Pharmaceuticals and IQVIA Consulting.

He has worked on developing disruptive, competitive and sustainable business model for biosimilar business in his previous assignment. He understands the nuances of biopharma manufacturing and has spearheaded commercial discussions with top suppliers of biopharma equipment in the past.

During his consulting stint, he has led projects involving asset portfolio strategy, market entry strategy, commercial due diligence, opportunity assessment for novel therapies in Japan, Asia-Pacific, US, and Europe. He has a rich exposure of working across a breadth of therapeutic areas involving oncology, immunology, neurology, respiratory, rare diseases, and metabolic disorders.

Keval has completed his MBA from the prestigious Indian Institute of Management, Lucknow (India) and did his B.Tech. in Dairy Technology from Dairy Science College, Anand (Gujarat, India).

Related resources

AI驱动数据整理:原发性震颤流行病学迎来新方法 AI驱动数据整理:原发性震颤流行病学迎来新方法
Blog November 17, 2025
AI驱动数据整理:原发性震颤流行病学迎来新方法
药物再定位、真实世界数据和人工智能/机器学习(AI/ML):前景与机遇 药物再定位、真实世界数据和人工智能/机器学习(AI/ML):前景与机遇
Blog October 13, 2025
药物再定位、真实世界数据和人工智能/机器学习(AI/ML):前景与机遇
六家公司为“不可成药”靶点实现精准干预 六家公司为“不可成药”靶点实现精准干预
Blog October 7, 2025
六家公司为“不可成药”靶点实现精准干预
GLP-1减肥药美国市场版图争夺已演变成一场激烈角逐 GLP-1减肥药美国市场版图争夺已演变成一场激烈角逐
Blog October 3, 2025
GLP-1减肥药美国市场版图争夺已演变成一场激烈角逐